Indian pharmaceuticals market is expected to be worth USD 33.18 billion and reach 9th position in the global pharma market by 2023.
Based on the overall revenue (except for Piramal where only pharma business division revenue is considered) the top 15 pharmaceutical companies in India are:
Sun Pharmaceutical Industries Limited is a multinational company and was established by Mr. Dilip Shanghvi in 1983 offering products to treat psychiatry ailments. Today the company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology.
Sun Pharmaceutical is India's largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 273.28 billion which was 15.13% less than the revenue in FY 2017.
Aurobindo Pharma was established in 1986 and it's key business segments are APIs, Formulations and Packaging. Aurobindo Pharma sells over 300 products in over 125 countries. About 35% sales are generated through APIs, and About 65% of the company’s revenue is generated from formulations business, of which 63% of formulation sales comes from United States.
Aurobindo Pharma is India's second largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 164.99 billion which saw an increase of 9.34% over the revenue in FY 2017.
Lupin was established in 1968 and it's key business segments are APIs and Formulations, and the company manufactures and markets pharmaceutical products in all major markets across the globe. Lupin has presence in key growth therapies such as Cardiology, Central Nervous System, Diabetology, Respiratory, Gynecology, Anti-Infective, Gastro-Intestinal and Oncology.
Lupin is India's third largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 159.55 billion which declined by 9.35% compared to revenue in FY 2017.
Chemical, Industrial & Pharmaceutical Laboratories, now known as Cipla, was incorporated 1935. Cipla Limited was founded by Dr. K.A. Hamied. Cipla is a therapy leader in India for anti-malarial with a market-share of over 34%.
Cipla is India's fourth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 155.77 billion which saw an increase of 4.83% over the revenue in FY 2017.
Dr. Reddy’s Laboratories is headquartered in Hyderabad and was founded in 1984. The company manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.
Dr. Reddy’s Laboratories is India's fifth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 144.36 billion which saw an increase of 0.48% over the revenue in FY 2017.
Cadila Healthcare Limited was founded in 1952. Zydus Cadila provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products.
Cadila Healthcare Limited is India's sixth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 120.50 billion which saw an increase of 24.21% over the revenue in FY 2017.
Intas was founded in 1984. Intas has 13 commercialized biosimilars including Docetaxel & Paclitaxel. As on date, Intas continues its R&D efforts in chronic disease areas such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies. Intas has 14 formulation manufacturing facilities, of which seven are located in India, and the rest in the U.K. and Mexico.
Intas Pharmaceuticals is India's seventh largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 108.86 billion which saw an increase of 29.84% over the revenue in FY 2017.
Glenmark Pharma Limited was founded in 1977. Glenmark is a research driven organization which is focused on discovering novel molecules and developing high quality generics for the people all around the globe. With focus towards innovation and a robust growth framework, the company's drug discovery endeavours continue to play a vital role in the therapeutic areas of dermatology, respiratory and oncology.
Glenmark Pharma Limited is India's eighth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 91.86 billion which saw a decrease of 0.21% over the revenue in FY 2017.
Torrent Pharmaceuticals Limited was founded in 1959. The company is engaged in manufacturing and marketing of branded and unbranded generic formulations. Currently, the company consumes most of the APIs manufactured in its facility, and only a fraction is sold to the external consumers. Also, the company is engaged in contract manufacturing of formulations for pharmaceutical majors. For the last fifteen years, Torrent Pharmaceuticals has been manufacturing Insulin for Novo Nordisk Indian operations
Torrent Pharmaceuticals is India's ninth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 63.01 billion which saw an increase of 3.63% over the revenue in FY 2017.
ManKind Pharma Limited was founded in 1995. The company is engaged in manufacturing of a wide range of products – Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular, Dermal, Erectile Dysfunction, and several other categories.
ManKind Pharma is India's tenth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 52.00 billion which saw an increase of 16.67% over the revenue in FY 2017.
Biocon Limited was founded in 1978. From being an enzyme venture, Biocon successfully emerged as a biotechnology company in less than two decades time and now is a fully-integrated Biopharmaceutical company. The parent company’s key subsidiaries are Syngene International Limited, Biocon Biopharmaceuticals Private Limited, Biocon Research Limited, Switzerland-based Biocon SA and Malaysia-based Biocon SDN.BHD. Also, The Company owns 50% stake in Abu Dhabi-based NeoBiocon FZ.
Biocon Limited is India's eleventh largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 43.36 billion which saw an increase of 6.33% over the revenue in FY 2017.
Piramal Enterprises Limited was founded in 1988.The Company is in the pharma, critical care, consumer products, phytomedicine and imaging. For this ranking only the pharmaceuticals division's revenue was considered.
Piramal is India's twelfth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 43.22 billion which saw an increase of 11.03% over the revenue in FY 2017.
Wockhardt Limited was founded in 1960s. Wockhardt has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.
Wockhardt Limited is India's thirteenth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 40.57 billion which saw a decrease of 1.74% over the revenue in FY 2017.
Divis Laboratories Limited was founded in 1990. Divis Laboratories business segments are Active Pharma Ingredients, Nutraceuticals and intermediates. The company exports over 90% of manufactured products to foreign countries and only 8%-10% is consumed in India yearly. The company derives nearly 90% of revenues from developed economies such as Europe and US.
Divis Laboratories is India's fourteenth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 40.26 billion which saw a decrease of 3.70% over the revenue in FY 2017.
Abbott India Limited was founded in 1944. Abbott India Limited is public listed company and a subsidiary of Abbott Laboratories USA. Abbott India has headquarters in Mumbai, Maharashtra. The company manufactures pharmaceutical drugs and enjoys strong brand equity multiple therapeutic categories such as Women's Health, Gastroenterology, Neurology, Thyroid, Diabetes, Urology, Pain Management, Vitamins, Anti-Infectives & other therapy areas. Abbott India has a state-of-the-art formulation plant at Verna, Goa designed to produce high quality, high volume formulations.
Abbott India Limited is India's fifteenth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 34.24 billion which saw an increase of 14.29% over the revenue in FY 2017.
Information source: https://www.marketresearchreports.com/blog/2019/04/11/top-15-pharma-companies-india
If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock